The European Pharmacopoeia 6.7 describes a liquid chromatography (LC) method for the quantification of sulindac, using a quaternary mobile phase including chloroform and with a rather long run time. In the present study, a new method using a short sub-2µm column, which can be used on a classical HPLC system, was developed. The new LC conditions (without chloroform) were optimized by means of a new methodology based on design of experiments in order to obtain an optimal separation.
MATERIALS AND METHODS
Analyses were performed on an Agilent technologies HPLC 1100 series.
Chromatographic conditions: reference method
Analytical column: Alltima Silica column (250 x 4.6 mm i.d., 10 µm particle size) -Mobile phase: Acetic acid/ethanol/ethylacetate/ chlroroform (1:4:100:400 (v/v/v/v)) -Flow-rate: 2.0mL/minTemperature: 20°C -Detection : UV at 280 nm -Injection volume: 20µL
RESULTS

Apparatus
Chromatographic conditions: Optimised method
Experimental design
Analytical column: Platinum C18 Rocket column (53 x 7 mm i.d., 1.5µm particle size) -Mobile phase: ACN/buffer pH2 (see experimental design section) -Flow-rate: 3.0mL/min -Temperature: 35°C -Detection : UV at 340 nm -Injection volume: 100µL
Four HPLC factors were investigated using DoE methodology through a design matrix. All of the factors were quantitative (see table 1 ). The objective of this study was to determine the optimal chromatographic conditions allowing us to obtain a separation criterion of at least 0 minutes (i.e. baseline resolved peaks) with a probability of at least 90%.
A summary of the optimal values for each factor allowing the achievement of the higher probability ensuring a separation of at least 0 minutes with baseline-resolved peaks is shown in Table 2 .
Optimal values P(separation> 0)>0.9 1 40.5 55 3.6
The developed HPLC method for the quantification of sulindac and its related impurities divided the run time of analyses by three compared to the reference method. Figure 4a and 4b show the optimal predicted and experimental chromatograms. As can be seen, the predicted retention times were found to be very close to the experimental values and an acceptable separation was obtained within an analysis time of 6 minutes. 
RESULTS
Reference method
Figure 1 : Chromatogram of the reference method.
Optimised method
As can be seen in Figure 1 , the reference method enabled the separation of all the compounds within 18 minutes and was completed within 25 minutes. Figure 2 illustrates the quality of the fit of the observed retention times versus the predicted retention times using the statistical models previously described. Most of the residuals were mainly located within the interval [-0.2 min, 0.2 min]. Figure 3 shows the probability surfaces in different directions of the space around the optimal solution (for each graph, two factors were fixed at their optimal values). As we can see, the best probability surface was obtained when the duration of the initial isocratic plate was around 1 minute. An analytical method for the quantification of sulindac and its related impurities was developed using a short column with sub-2 µm particles on a classical HPLC system. This method was optimised using DoE methodology and the DS concept. Under optimised conditions, the analysis time was considerably reduced (by about 3-fold). Furthermore, we did not use chloroform unlike in the EP reference method. Finally, this particular method was validated successfully using an accuracy profiles approach for sulindac and its related substances.
Figure 5 : Accuracy profiles of (a) sulindac, (b) E-sulindac, (c) sulphide and (d) sulphone. Relative bias (-), ± 5% acceptance limits (---), 95% (sulindac) or 85% (related impurities) β-expectation tolerance limits (---), and relative back-calculated concentrations (•).
Validation method
The calibration and validation standards were prepared by mixing and diluting the stock solutions with phosphate buffer solution (pH 7.4; 50 mM) to reach the concentration levels: 100/10; 100/5; 100/1; 100/0.5; 50/0.25; 25/0.125; 1/0.005; 0.5/0.0025 µg/ml (sulindac concentration/ concentrations of related impurities, respectively.
An original approach using accuracy profiles based on tolerance intervals was applied to evaluate the reliability of the results. The tolerance interval used was a "β-expectation tolerance interval" defining an interval in which it is expected that each future result will fall with a defined probability (β). It is therefore a predictive methodology. This tolerance interval is computed for each validation standard concentration level, using their estimated intermediate precision standard deviation and bias. By joining together the upper tolerance limits on the one hand and the lower tolerance limits on the other hand, the method defines an accuracy profile ( fig.5 ).
